Coalition Asks Senate to Focus on Patient Access to Care
Coalition tells Senate committee that real patient interests trump potential “conflicts of interest” as nation expands access to care.
May 16, 2013 – The Centers for Medicare & Medicaid Services (CMS) is likely “to find itself the target of ... read more
May 14, 2013 — In a Medical Marketing and Media (MMM) column posted May 1, Coalition for Healthcare Communication Executive ... read more
May 14, 2013 — The FDA’s Office of Prescription Drug Promotion (OPDP) will be holding an Enforcement Webinar May 16, ... read more
May 6, 2013 — With Sunshine Act reporting slated to begin in less than three months, it is sobering to ... read more
April 29, 2013 – Although the Digital Advertising Alliance (DAA) has made great strides to protect consumers’ privacy online – ... read more
April 22, 2013 – In April 18 comments to the Centers for Medicare & Medicaid Services (CMS) the Coalition for ... read more
April 4, 2013 – A new White Paper, “FDA Communications Oversight in a Digital Era,” issued April 2 by Eye ... read more
April 4, 2013 — Headlines run by news outlets regarding the status of industry-physician relationships rarely focus on the benefits ... read more
April 1, 2013 – By John Kamp, Executive Director, Coalition for Healthcare Communication While not directly about communication and marketing, ... read more
March 22, 2013 – Although spending on drug promotion has declined in recent years, 2013 could be a pivotal year ... read more
March 19, 2013 – Although the FDA has not yet issued its long-awaited social media guidance for the biopharma industry, ... read more
March 11, 2013 – Healthcare industry collaborations with physicians and researchers have “been at the heart of most of the ... read more
March 4, 2013 – A recent study released by the National Bureau of Economic Research (NBER) states that although consumer-directed ... read more
Feb. 25, 2013 – The Centers for Medicare & Medicaid (CMS) launched its “OPENPAYMENTS” Website last week, which will be ... read more
On Feb. 1, the Centers for Medicare & Medicaid Services (CMS) issued a final rule implementing the Sunshine Act provisions ... read more
Many Questions Still Unresolved Feb. 4, 2013 – Although the final rule to implement the Sunshine provisions of the Affordable ... read more
Jan. 15, 2013 – If 2012 – with its high number of new drug approvals, senior staff stability within the ... read more
Nov. 27, 2012 – An Oct. 31 enforcement letter from the FDA’s Office of Prescription Drug Promotion (OPDP) to Cornerstone ... read more
Feb. 23, 2012 – At a White House meeting held today to unveil the blueprint for the Obama Administration’s “Consumer ... read more
By John Kamp, Executive Director, Coalition for Healthcare Communication July 18, 2011 — For those who have not read the ... read more
Coalition tells Senate committee that real patient interests trump potential “conflicts of interest” as nation expands access to care.
From DTC Perspectives:
Representatives John Fleming and Frank Pallone set Erin Burnett of CNBC straight on the value of DTC and why removing its tax deductibility is not a good idea.
Washington lobbyists working with the Advertising Coalition breathed a bit easier Friday when learning that the Ad Tax Provision was not likely to be in the House revenue options for funding healthcare reform. But watch the news carefully.
Read more
The Advertising Coalition and the AAAA D.C. office report that elimination of the tax deduction for marketing costs for drug and related businesses is still among the revenue options to pay for healthcare reform (HCR).
Read more
The Coalition has developed an aggressive plan to address the FDA’s recent “draft guidance” for including risk information in advertising and other marketing materials.
Under the leadership of Harry Sweeney, the Coalition has developed an aggressive plan to address the FDA’s recent “draft guidance” for presenting risk information in advertising and other marketing materials.
Read more
Read the Coalition’s Amici Brief, submitted to appeals court, defending marketing use of prescription data and asserting First Amendment rights.
The American Association of Advertising Agencies, along with other members of The Advertising Coalition, are aggressively opposing all efforts to restrict the deductibility of prescription drug advertisements. The deductibility proposal, which has been discussed in Congress and at The White House, is an area of a new revenue package being considered as part of a new healthcare reform.
The Advertising Coalition, of which the 4A’s is a founding member, is coordinating the industry’s efforts to defeat any changes to the deductibility rules. The broad coalition comprises marketers, clients and media outlets.
Download the Letter Sent by The Advertising Coalition to President Obama
“This is a very real and an extremely serious threat,” said Dick O’Brien, head of the 4A’s Washington office. O’Brien and other 4A’s staff and members with medical accounts have been meeting with Congressional leaders and key members of the House Ways and Means Committee and the Senate Finance Committee to educate them about the effect such a change would have on consumers and on marketers and media.
For more information about the 4A’s efforts, contact the 4A Washington office, 202-331-7345.
Recent Comments